SAB Biotherapeutics reports Q1 2026 results, enrollment progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: SABS) | Delayed: 2.84 -0.2 (6.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $ | |||
| Open | $2.98 | 52 Week Low | $ | |||
| Day High | $3.04 | P/E | N/A | |||
| Day Low | $2.82 | EPS | $ | |||
| Volume | 1,015,771 | |||||
| (NASDAQ: SABSW) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 1,015,771 | |||||
